The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

 
Web www.patentalert.com

< Non-invasive method for optimizing the respiration of atelectatic lungs

> Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF.alpha.) signaling pathway
~ 00405